VitaNova Life Sciences (VNOV) Gross Profit (2017 - 2026)

VitaNova Life Sciences has disclosed Gross Profit across 4 years of filings, most recently posting $30521.0 for Q3 2026.

• Gross Profit for Q3 2026 came in at $30521.0, down 55.63% year-over-year; the trailing twelve-month figure through Jul 2026 was $872329.0 (down 44.48% YoY), and the FY2026 annual result was $910589.0, down 42.21% from the prior year.
• Gross Profit for Q3 2026 stood at $30521.0, down from $264662.0 in the prior quarter.
• Across five years, Gross Profit topped out at $1.2 million in Q2 2025 and bottomed at $26100.0 in Q1 2024.
• Average Gross Profit over 3 years is $263139.2, with a median of $189312.0 recorded in 2025.
• The widest annual swing landed in 2025, when Gross Profit jumped 625.33%; it then tumbled 77.13% in 2026.
• Year by year, Gross Profit stood at $155834.0 in 2024, then jumped by 67.36% to $260803.0 in 2025, then sank by 88.3% to $30521.0 in 2026.
• The last three Gross Profit figures came in at $30521.0 (Q3 2026), $264662.0 (Q2 2026), and $316343.0 (Q1 2026), per Business Quant data.